medigraphic.com
ISSN 1527-3172 (Digital)

2020, Número 4

<< Anterior Siguiente >>

MEDICC Review 2020; 22 (4)


SARS-CoV-2 Transmission Channels: A Review of the Literature

Abd El-Wahab EW, Eassa SM, Metwally M, Al-Hraishawi H, Omar SR

Idioma: Ingles.
Referencias bibliográficas: 301
Paginas: 51-69
Archivo PDF: 140.85 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Singhal T. A review of Coronavirus disease- 2019 (COVID-19). Indian J Pediatr. 2020 Apr;87(4):281–6.

  2. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Coronavirus disease (COVID-2019). Situation reports. Coronoavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update; [cited 2020 Aug 2]. Available at: https://www .who.int/emergencies/diseases/novel-coronavi rus-2019/situation-reports

  3. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564–7.

  4. Lesho E, Laguio-Vila M, Walsh E. Stability and Viability of SARS-CoV-2. N Engl J Med. 2020 May 14;382(20):1963–4.

  5. Rubens JH, Karakousis PC, Jain SK. Stability and Viability of SARS-CoV-2. N Engl J Med. 2020 May 14;382(20):1962–3.

  6. Schwartz KL, Kim J, Garber G. Stability and Viability of SARS-CoV-2. N Engl J Med. 2020 May 14;382(20):1963.

  7. Helmers A. Stability and Viability of SARS-CoV-2. N Engl J Med. 2020 May 14;382(20):1964.

  8. Petti S. Stability and Viability of SARS-CoV-2. N Engl J Med. 2020 May 14;382(20):1964–5.

  9. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020 Mar;104(3):246–51.

  10. Grass G, Rensing C, Solioz M. Metallic copper as an antimicrobial surface. Appl Environ Microbiol. 2011 Mar;77(5):1541–7.

  11. Pastorino B, Touret F, Gilles M, de Lamballerie X, Charrel RN. Evaluation of heating and chemical protocols for inactivating SARS-CoV-2. bioRxiv [Internet]. Yale: BMJ Yale; 2020 Apr 11 [cited 2020 Apr 20]. Available at: https://www.biorxiv .org/content/10.1101/2020.04.11.036855v1

  12. Chin A, Chu J, Perera M, Hui K, Yen H-L, Chan M, et al. Stability of SARS-CoV-2 in different environmental conditions. medRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Mar 27 [cited 2020 Apr 20]. Available at: https://www.medrxiv .org/content/10.1101/2020.03.15.20036673v2 .article-info

  13. National Health Commission of the People’s Republic of China [Internet]. Beijing: National Health Commission of the People’s Republic of China; c2020. News. No evidence to suggest coronavirus will disappear in summer: WHO expert; 2020 Mar 7 [cited 2020 Mar 7]. Available at: http://en.nhc.gov.cn/2020-03/07/c_77446.htm

  14. Bukhari Q, Jameel Y. Will coronavirus pandemic diminish by summer?[Internet].New York: SSRN; 2020 Mar 19 [cited 2020 Apr 20]. Available at: https://dx.doi.org/10.2139/ssrn.3556998

  15. Wang J, Tang K, Feng K, Lin X, Lv W, Chen K, et al. High temperature and high humidity reduce the transmission of COVID-19 [Internet]. New York: SSRN; 2020 Mar 10 [cited 2020 Apr 20]. 33 p. Available at: https://papers.ssrn.com/sol3/ papers.cfm?abstract_id=3551767

  16. Sajadi MM, Habibzadeh P, Vintzileos A, Shokouhi S, Miralles-Wilhelm F, Amoroso A. Temperature, humidity and latitude analysis to predict potential spread and seasonality for COVID-19 [Internet]. New York: SSRN; 2020 Mar 9 [cited 2020 Apr 20].18 p. Available at: http://dx.doi.org/10.2139/ ssrn.3550308

  17. Lipsitch M. Seasonality of SARS-CoV-2: Will COVID-19 go away on its own in warmer weather? [Internet]. Boston: Harvard T.H. Chan School of Public Health; 2020 [cited 2020 Jul 31]; [about 2 p.]. Available at: https://ccdd.hsph.harvard .edu/will-covid-19-go-away-on-its-own-in-warmer -weather/

  18. Wu Y, Jing W, Liu J, Ma Q, Yuan J, Wang Y, et al. Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries. Sci Total Environ. 2020 Aug 10;729:139051. DOI: 10.1016/j.scitotenv. 2020.139051.

  19. Mecenas P, Bastos R, Vallinoto A, Normando D. Effects of temperature and humidity on the spread of COVID-19: A systematic review. medRxiv [Internet].New York: Cold Spring Harbor Lab; 2020 Apr 17 [cited 2020 Jul 15]. 31 p. Available at: https://www.medrxiv.org/content/10.1101 /2020.04.14.20064923v1.full.pdf+html

  20. Kowalski W, Walsh T, Petraitis V. 2020 COVID- 19 Coronavirus Ultraviolet Susceptibility. Techniqual report. PurpleSun Inc2020 [Internet]. Berlin: ResearchGate; 2020 Mar [cited 2020 Jul 15]; [about 3 p.]. Available at: https://www.researchgate.net/publi cation/339887436_2020_COVID-19_Coro navirus_Ultraviolet_Susceptibility

  21. Bianco A, Biasin M, Pareschi G, Cavalleri A, Cavatorta C, Fenizia C, et al. UV-C irradiation is highly effective in inactivating and inhibiting SARS-CoV-2 replication. medRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Jun 23 [cited 2020 Jul 15]. Available at: https://www.medrxiv .org/content/10.1101/2020.06.05.20123463v2

  22. Health Europe [Internet]. Congleton (UK): Pan European Networks Ltd; c2018. Infection Control News. Breakthrough ultraviolet light development could help kill COVID-19 virus; 2020 Jun 2 [cited 2020 Aug 2]; [about 2 p.]. Available at: https:// www.healtheuropa.eu/breakthrough-ultraviolet -light-development-could-help-kill-covid-19-vi rus/100409/

  23. Du Z, Xu X, Wu Y, Wang L, Cowling BJ, Meyers LA. Serial interval of COVID-19 among publicly reported confi rmed cases. Emerg Infect Dis. 2020 Jun;26(6):1341–3.

  24. Qian G, Yang N, Ma AHY, Wang L, Li G, Chen X, et al. COVID-19 Transmission within a family cluster by presymptomatic carriers in China. Clin Infect Dis. 2020 Jul 28;71(15):861–2.

  25. Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic Transmission of SARSCoV- 2—Singapore. MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):41–5.

  26. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–62.

  27. Liu WD, Chang SY, Wang JT, Tsai MJ, Hung CC, Hsu CL, et al. Prolonged virus shedding even after seroconversion in a patient with COVID-19. J Infect. Epub 2020 Apr 10.

  28. Zhou B, She J, Wang Y, Ma X. The duration of viral shedding of discharged patients with severe COVID- 19. Clin Infect Dis. 2020 Apr 17. pii: ciaa451. DOI: 10.1093/cid/ciaa451. [Epub ahead of print]

  29. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199–207.

  30. Dahl E. Coronavirus (Covid-19) outbreak on the cruise ship Diamond Princess. Int Marit Health. 2020;71(1):5–8.

  31. Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis. 2020 May;20(5):553–8. Epub 2020 Mar 11.

  32. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020 Mar 13;27(2).

  33. Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High Contagiousness and rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020 Jul 7;26(7):1470–7.

  34. Yuan J, Li M, Lv G, Lu ZK. Monitoring transmissibility and mortality of COVID-19 in Europe. Int J Infect Dis. 2020 Jun 95:311–5. Epub 2020 Mar 28.

  35. Cole EC, Cook CE. Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies. Am J Infect Control. 1998 Aug;26(4):453–64.

  36. Duguid JP. The size and the duration of aircarriage of respiratory droplets and dropletnuclei. J Hyg (Lond). 1946 Sep;44(6):471–9.

  37. Hamburger M Jr, Robertson OH. Expulsion of group A hemolytic streptococci in droplets and droplet nuclei by sneezing, coughing and talking. Am J Med. 1948 May;4(5):690–701.

  38. Loudon RG, Roberts RM. Relation between the airborne diameters of respiratory droplets and the diameter of the stains left after recovery. Nature. 1967 Jan 7;213(5071):95–6.

  39. Yang C, Ma QY, Zheng YH, Yang YX. [Transmission routes of 2019-novel coronavirus (2019- nCoV)]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Apr 6;54(4):374–7. Chinese.

  40. Fennelly KP. Particle sizes of infectious aerosols: implications for infection control. Lancet Respir Med. 2020 July 24;8(9):914–24.

  41. Somsen GA, van Rijn C, Kooij S, Bem RA, Bonn D. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med. 2020 Jul;8(7):658–9.

  42. Lewis D. Is the coronavirus airborne? Experts can‘t agree. Nature. 2020 Apr;580(7802):175.

  43. Medical Xpress [Internet]. Douglas (UK): Science X; c2011–2020. Diseases, Conditions, Syndroms. How Important Is Speech in Transmitting Coronavirus?; 2020 Apr 3 [cited 2020 May10]; [about 2 p.]. Available at: https://medicalxpress .com/news/2020-04-important-speech-transmit ting-coronavirus.html

  44. Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic [Internet]. Washington, D.C.: National Academies of Sciences, Engineering, and Medicine; 2020 Apr 1 [cited 2020 May 10]. 3 p. Available at: https://www.nap.edu/ catalog/25769/rapid-expert-consultation-on-the -possibility-of-bioaerosol-spread-of-sars-cov-2 -for-the-covid-19-pandemic-april-1-2020

  45. Bourouiba L. Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. JAMA. 2020 Mar 26. DOI: 10.1001/jama.2020.4756.

  46. Guo ZD, Wang ZY, Zhang SF, Li X, Li L, Li C, et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis. 2020 Jul;26(7):1583–91.

  47. Santarpia JL, Rivera DN, Herrera V, Morwitzer MJ, Creager H, Santarpia GW, et al. Transmission potential of SARS-CoV-2 in viral shedding observed at the University of Nebraska Medical Center. medRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Jun 3 [cited 2020 Jun 10]. 12 p. Available at: https://www.medrxiv.org/ content/10.1101/2020.03.23.20039446v2.full.pdf

  48. Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, et al. Aerodynamic characteristics and RNA concentration of SARS-CoV-2 aerosol in Wuhan hospitals during COVID-19 outbreak. bioRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Mar 10 [cited 2020 Mar 22]. Available at: https://www.biorxiv.org/content/10.1101/2020.03 .08.982637v1

  49. Cheng VCC, Wong S-C, Chen JHK, Yip CCY, Chuang VWM, Tsang OTY, et al. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol. 2020 May;41(5):493–8.

  50. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, surface environmental, and personal protective equipment contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020 Mar 4. DOI: 10.1001/ jama.2020.3227.

  51. Faridi S, Niazi S, Sadeghi K, Naddafi K, Yavarian J, Shamsipour M, et al. A fi eld indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran. Sci Total Environ. 2020 Jul 10;725:138401. Epub 2020 Apr 6.

  52. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Newsroom. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations; 2020 Mar 29 [cited 2020 Apr 26]; [about 5 p.]. Available at: https://www.who .int/news-room/commentaries/detail/modes-of -transmission-of-virus-causing-covid-19-implica tions-for-ipc-precaution-recommendations

  53. To KK, Tsang OT, Chik-Yan Yip C, Chan KH, Wu TC, Chan JMC, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis [Internet]. 2020 Jul 28 [cited 2020];71(15):841–3. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/ pmid/32047895/

  54. New insights into the transmissibility of the virus. Berlin: BioValley; 2020.

  55. Setti L, Passarini F, De Gennaro G, Barbieri P, Perrone MG, Borelli M, et al. Airborne transmission route of COVID-19: why 2 meters/6 feet of inter-personal distance could not be enough. Int J Environ Res Public Health. 2020 Apr 23;17(8).

  56. Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ. Identifying airborne transmission as the dominant route for the spread of COVID-19. Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):14857–63.

  57. Setti L, Passarini F, De Gennaro G, Barbieri P, Perrone MG, Piazzalunga A, et al. The potential role of particulate matter in the spreading of COVID-19 in Northern Italy: fi rst evidencebased research hypotheses. medRxiv [Internet]. New York: Cold Spring Harbor Lab;2020 Apr 17 [cited 2020 May 20]. Available at: https://www.medrxiv.org/content/10.1101/2020.0 4.11.20061713v1

  58. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Newsroom. Transmission of SARS-CoV-2: implications for infection prevention precautions; 2020 Jul 9 [cited 2020 Jul 31]; [about 10 p.]. Available at: https://www.who.int/news-room/commentaries/ detail/transmission-of-sars-cov-2-implications -for-infection-prevention-precautions

  59. Pancic F, Carpentier DC, Came PE. Role of infectious secretions in the transmission of rhinovirus. J Clin Microbiol. 1980 Oct;12(4):567–71.

  60. Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association. [An update on the epidemiological characteristics of novel coronavirus pneumonia COVID-19]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):139– 44. Chinese.

  61. Hamzelou J. Should you disinfect your online shopping? New Sci. 2020 Apr 4;245(3276):12.

  62. New Group of Experts on the prevention and control of Chinese Preventive Medicine Association coronavirus pneumonia. The latest understanding of the epidemiological characteristics of pneumonia novel coronavirus. Chinese J Epidemiol. 2020.

  63. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A fi rst step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631–7.

  64. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019- nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020 Feb 24;12(1):8.

  65. Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Jan 31 [cited 2020 Feb 19]. Available at: https://www.biorxiv.org/content/10.1101/2020.01 .30.927806v1

  66. Sahu KK, Mishra AK, Lal A. COVID-2019: update on epidemiology, disease spread and management. Monaldi Arch Chest Dis. 2020 Apr 16;90(1).

  67. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020 May;158 (6):1831–3.

  68. Kotfi s K, Skonieczna-Zydecka K. COVID-19: gastrointestinal symptoms and potential sources of 2019-nCoV transmission. Anaesthesiol Intensive Ther. 2020;52(2):172–3.

  69. Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecaloral transmission. Gastroenterology. 2020 May;158(6):1518–9.

  70. World Health Organization. Report of the WHOChina Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. Geneva: World Health Organization; 2020 Feb 16–24 [cited 2020 Apr 27]. Available at: https://www.who. int/docs/defaultsource/coronaviruse/who-china -joint-mission-on-covid-19-fi nal-report.pdf

  71. Yong Z, Cao C, Shuangli Z, Chang S, Dongyan W, Jingdong S, et al. Isolation of 2019-nCoV from a Stool Specimen of a Laboratory-Confi rmed Case of the Coronavirus Disease 2019 (COVID- 19). China CDC Weekly. 2020;2(8):123–4.

  72. Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020 Apr;20(4):411–2.

  73. Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 Apr 21;369:m1443.

  74. Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology. 2020 Jul;159(1):81–95.

  75. Bulut C, Kato Y. Epidemiology of COVID-19. Turk J Med Sci. 2020 Apr 21;50(SI-1):563–70.

  76. Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 2020 Feb 26;9(1):469–73.

  77. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. New Engl J Med. 2020 Mar 5;382(10):929–30.

  78. Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus–infected pneumonia. J Med Virol. 2020 Jun;92(6):680–2.

  79. Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020 Apr;5(4):335–7.

  80. Nouri-Vaskeh M, Alizadeh L. Fecal transmission in COVID-19: a potential shedding route. J Med Virol. 2020 Apr 1. DOI: 10.1002/jmv.25816. [Epub ahead of print]

  81. Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020 Jul;92(7):833–40.

  82. Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020 May;5(5):434–5.

  83. Xiao F, Sun J, Xu Y, Li F, Huang X, Li H, et al. Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerg Infect Dis. 2020 Aug;26(8):1920–2.

  84. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020 Mar 11. DOI: 10.1001/jama.2020.3786. [Epub ahead of print]

  85. Chan WM, Yuen KS, Fan DS, Lam DS, Chan PK, Sung JJ. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br J Ophthalmol. 2004 Jul;88(7):968–9.

  86. Lu CW, Liu XF, Jia ZF. 2019 nCoV transmission through the ocular surface must not be ignored. Lancet. 2020 Feb 22;395(10224):e39.

  87. Seah I, Agrawal R. Can the Coronavirus disease 2019 (COVID-19) affect the eyes? A review of Coronaviruses and ocular implications in humans and animals. Ocul Immunol Infl amm. 2020 Apr 2;28(3):391–5.

  88. Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020 Aug 4;173(3):242–3.

  89. Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al. Ocular manifestations of a hospitalised patient with confi rmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020 Jun;104(6):748–51.

  90. Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID- 19): a case report. Can J Ophthalmol. 2020 Aug;55(4):e125–9.

  91. Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Are ocular symptoms common in patients with COVID- 19? [Internet]. New York: SSRN; 2020 Apr 1 [cited 2020 May 27]. 38 p. Available at: https:// papers.ssrn.com/sol3/papers.cfm?abstract _id=3559539

  92. Liang L, Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. 2020 May;98(3):223. DOI: 10.1111/ aos.14413.

  93. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular fi ndings of patients with Coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020 Mar 31. DOI: 10.1001/jamaophthalmol.2020.1291 [Epub ahead of print]

  94. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18)1708–20.

  95. Peng Y, Zhou YH. Is novel coronavirus disease (COVID-19) transmitted through conjunctiva? J Med Virol. 2020 Mar 16. DOI: 10.1002/ jmv.25753. [Epub ahead of print]

  96. Kuo IC. A Rashomon moment? Ocular involvement and COVID-19. Ophthalmology. 2020 Jul;127(7):984–5.

  97. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Medical Virol. 2020 Jun;92(6):589–94.

  98. Jun ISY, Anderson DE, Kang AEZ, Wang L-F, Rao P, Young BE, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020 Jul;127(7):977–9.

  99. Jones L, Walsh K, Willcox M, Morgan P, Nichols J. The COVID-19 pandemic: Important considerations for contact lens practitioners. Cont Lens Anterior Eye. 2020 Jun;43(3):196–203.

  100. Dong L, Tian J, He S, Zhu C, Wang J, Liu C, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. 2020 Mar 26.DOI: 10.1001/jama.2020.4621. [Epub ahead of print]

  101. Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J, et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr. 2020 Mar 26. DOI: 10.1001/jamapediatrics.2020.0878. [Epub ahead of print]

  102. Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W, et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA. 2020 Mar 26. DOI: 10.1001/jama.2020.4861.

  103. Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol. 2020 Jun;37(8):861–5.

  104. Kimberlin DW, Stagno S. Can SARS-CoV-2 infection be acquired in utero?: more defi nitive evidence is needed. JAMA. 2020 Mar 26. DOI: 10.1001/jama.2020.4868.

  105. Ashraf MA, Keshavarz P, Hosseinpour P, Erfani A, Roshanshad A, Pourdast A, et al. Coronavirus Disease 2019 (COVID-19): asystematic review of pregnancy and the possibility of vertical transmission. J Reprod Infertil. 2020 Jul– Sep;21(3):157–68.

  106. Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020 Feb;9(1):51–60.

  107. Li Y, Zhao R, Zheng S, Chen X, Wang J, Sheng X, et al. Lack of vertical transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerg Infect Dis. 2020 Jun;26(6):1335–6.

  108. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020 Mar 7;395(10226):809–15.

  109. Schwartz DA. An Analysis of 38 Pregnant women with COVID-19, their newborn infants, and maternal fetal transmission of SARS-CoV-2: maternal Coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020 Mar 17.DOI: 10.5858/ arpa.2020-0901-SA. [Epub ahead of print]

  110. Zhang L, Jiang Y, Wei M, Cheng BH, Zhou XC, Li J, et al. [Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province]. Zhonghua Fu Chan Ke Za Zhi. 2020 Mar 25;55(3):166–71. Chinese.

  111. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020 May;222(5):415–26.

  112. Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, Abbasi H, Mirjalili SR, Behforouz A, et al. Vertical transmission of Coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol. 2020 Jun;39(3):246–50.

  113. Yang H, Wang C, Poon LC. Novel coronavirus infection and pregnancy. Ultrasound Obstetrics Gynecol. 2020 Apr;55(4):435–7.

  114. Bouthry E, Picone O, Hamdi G, Grangeot–Keros L, Ayoubi JM, Vauloup–Fellous C. Rubella and pregnancy: diagnosis, management and outcomes. Prenat Diagn. 2014 Dec;34(13):1246–53.

  115. Schmid MB, Fontijn J, Ochsenbein-Kölble N, Berger C, Bassler D. COVID-19 in pregnant women. Lancet Infect Dis. 2020 Jun;20(6):653. DOI: 10.1016/S1473-3099(20)30175-4.

  116. Ferrazzi E, Frigerio L, Savasi V, Vergani P, Prefumo F, Barresi S, et al. Vaginal delivery in SARS-CoV-2 infected pregnant women in Northern Italy: a retrospective analysis. BJOG. 2020 Apr 27. DOI: 10.1111/1471-0528.16278. [Epub ahead of print]

  117. Iqbal SN, Overcash R, Mokhtari N, Saeed H, Gold S, Auguste T, et al. An uncomplicated delivery in a patient with Covid-19 in the United States. N Engl J Med. 2020 Apr 16;382(16):e34.

  118. Xiong X, Wei H, Zhang Z, Chang J, Ma X, Gao X, et al. Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID19. J Med Virol. 2020 Apr 10. DOI: 10.1002/jmv.25857.

  119. Grob R, Conzelmann C, Müller JA, Stenger S, Steinhart K, Kirchhoff F, et al. Detection of SARS-CoV-2 in human breastmilk. Lancet. 2020 Jun 6;395(10239):1757–8.

  120. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Newsroom. Breastfeeding and COVID-19; 2020 Jun 23 [cited 2020 July 31]; [about 3 p.]. Available at: https://www.who.int/news-room/commentaries/ detail/breastfeeding-and-covid-19

  121. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC); c2020. Breastfeeding. Coronavirus disease (COVID-19) and breastfeeding; 2020 [cited 2020 Apr 28]. Available at: https://www.cdc.gov/breastfeeding/breastfeed ing-special-circumstances/maternal-or-infant -illnesses/covid-19-and-breastfeeding.html

  122. Hussein J. COVID-19: What implications for sexual and reproductive health and rights globally? Sex Reprod Health Matters. 2020 Dec;28(1):1746065. DOI: 10.1080/ 26410397.2020.1746065.

  123. Pan F, Xiao X, Guo J, Song Y, Li H, Patel DP, et al. No evidence of severe acute respiratory syndrome- coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril. 2020 Jun;113(6):1135–9.

  124. Song C, Wang Y, Li W, Hu B, Chen G, Xia P, et al. Detection of 2019 novel coronavirus in semen and testicular biopsy specimen of COVID-19 patients. medRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Apr 10 [cited 2020 May 20]. Available at: https://www.medrxiv.org/content/10 .1101/2020.03.31.20042333v2.full.pdf

  125. Cui P, Chen Z, Wang T, Dai J, Zhang J, Ding T, et al. Clinical features and sexual transmission potential of SARS-CoV-2 infected female patients: a descriptive study in Wuhan, China. medRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Feb 27 [cited 2020 Mar 15]. Available at: https://www.medrxiv.org/content/10.1101 /2020.02.26.20028225v1.full.pdf

  126. Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020 May 1;3(5):e208292.

  127. Patri A, Gallo L, Guarino M, Fabbrocini G. Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a new possible route of infection? J Am Acad Dermatol. 2020 Jun;82(6):e227. DOI: 10.1016/j. jaad.2020.03.098.

  128. Wang Z, Xu X. scRNA-seq profi ling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in Spermatogonia, Leydig and Sertoli cells. Cells. 2020 Apr 9;9(4):pii: E920.

  129. Murdoch DR, French NP. COVID-19: another infectious disease emerging at the animal- human interface. N Z Med J. 2020 Feb 21;133(1510):12–5.

  130. Salata C, Calistri A, Parolin C, Palů G. Coronaviruses: a paradigm of new emerging zoonotic diseases. Pathog Dis. 2019 Dec 12;77(9). pii: ftaa006.DOI: 10.1093/femspd/ftaa006.

  131. Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect. 2020 Jun;53(3):365–7.

  132. Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the newly identifi ed Coronavirus 2019-nCoV. J Med Virol. 2020 Apr;92(4):433–40.

  133. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–3.

  134. Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G,Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020 Apr;79:104212. DOI: 10.1016/j.meegid.2020.104212.

  135. Callaway E, Cyranoski D. Why snakes probably aren’t spreading the new China virus. London: Springer Nature; 2020 Jan 23 [cited 2020 Apr 25]. Available at: https://www.nature.com/ articles/d41586-020-001808?fbclid=IwAR2Wh sY7rHjI86vgRpyiaUYQkvvKR9mjYrbI3LxBL8xo qJVhnGmr5d4MZiY

  136. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus–The species and its viruses, a statement of the Coronavirus Study Group. bioRxiv [Internet]. NewYork: Cold Spring Harbor Lab; 2020 Feb 11 [cited 2020 Mar 19]. Available at: https://www.biorxiv .org/content/10.1101/2020.02.07.937862v1

  137. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb 22;395(10224):565–74.

  138. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–33.

  139. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identifi cation of a novel Coronavirus causing severe pneumonia in human: a descriptive study. Chinese Med J (Engl). 2020 May 5;133(9):1015–24.

  140. Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019-new coronavirus epidemic: evidence for virus evolution. J Medi Virol. 2020 Apr;92(4):455–9.

  141. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the novel Coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS Coronavirus. J Virol. 2020 Mar 17;94(7). pii: e00127-20. DOI: 10.1128/JVI.00127-20.

  142. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020 Apr;26(4):450–2.

  143. Calisher C, Carroll D, Colwell R, Corley RB, Daszak P, Drosten C, et al. Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19. Lancet. 2020 Mar 7;395(10226):e42–e3.

  144. Biscayart C, Angeleri P, Lloveras S, Chaves TDSS, Schlagenhauf P, Rodríguez-Morales AJ. The next big threat to global health? 2019 novel coronavirus (2019-nCoV): what advice can we give to travellers?–Interim recommendations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI). Travel Med Infect Dis. 2020;33:101567.

  145. Rodríguez-Morales AJ, Bonilla-Aldana DK, Balbin- Ramon GJ, Rabaan AA, Sah R, Paniz-Mondolfi A, et al. History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus epidemic. Infez Med. 2020 Mar 1;28(1):3–5

  146. Ahmad T, Khan M, Haroon, Musa TH, Nasir S, Hui J, et al. COVID-19: zoonotic aspects. Travel Med Infect Dis. 2020 Feb 27:101607.

  147. Li HY, Zhu GJ, Zhang YZ, Zhang LB, Hagan EA, Martinez S, et al. A qualitative study of zoonotic risk factors among rural communities in southern China. Int Health. 2020 Feb 12;12(2):77–85.

  148. Almendros A. Can companion animals become infected with Covid-19? Vet Rec. 2020 Mar 28;186(12):388–9.

  149. Parry NMA. COVID-19 and pets: when pandemic meets panic. Forensic Sci Int: Reports. 2020 Dec;2:100090.

  150. Sit THC, Brackman CJ, Ip SM, Tam KWS, Law PYT, To EMW, et al. Infection of dogs with SARS-CoV-2 [Internet]. London: Springer Nature; 2020 May 14 [cited 2020 Jun 16]; [about 6 p.]. Available at: https://www.nature.com/articles/s41586-020-23 34-5

  151. Li X. Can cats become infected with Covid-19? Vet Rec. 2020 Apr 18;186(14):457–8.

  152. Newman A, Smith D, Ghai RR, Wallace RM, Torchetti MK, Loiacono C, et al. First reported cases of SARS-CoV-2 infection in companion animals - New York, March- April 2020. MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):710–3.

  153. Oreshkova N, Molenaar R-J, Vreman S, Harders F, Munnink BBO, Hakze R, et al. SARS-CoV2 infection in farmed mink, Netherlands, April 2020. bioRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 May 18 [cited 2020 May 27]. Available at: https://www.biorxiv.org/content/10.1101/2020 .05.18.101493v1

  154. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC); Coronavirus disease (COVID-19).Your Health. COVID-19 and Animals; [updated 2020 Aug 24; cited 2020 Apr 28]. Available at: https://www.cdc.gov/coronavirus/2019 -ncov/daily-life-coping/animals.html

  155. Shanthikumar SR. We should err on side of caution with Covid-19 advice. Vet Rec. 2020 Apr 18;186(14):458. DOI: 10.1136/vr.m1488.

  156. Lu J, Gu J, Li K, Xu C, Su W, Lai Z, et al. Early release-COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China, 2020. Emerg Infect Dis. 2020 Jul;26:1320–3.

  157. Dietz L, Horve PF, Coil DA, Fretz M, Eisen JA, Van Den Wymelenberg K. 2019 novel Coronavirus (COVID-19) pandemic: built environment considerations to reduce transmission. mSystems. 2020 Apr 7;5(2).pii: e00245-20. DOI: 10.1128/mSystems.00245-20.

  158. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: Center for Disease Control and Prevention (CDC); c2020. Coronavirus Disease 2019 (COVID-19). Health Departments. COVID-19 and Cooling Centers; [updated 2020 Apr 11; cited 2020 Apr 28]. Available at: https://www.cdc.gov/coronavirus/2019 -ncov/php/cooling-center.html

  159. Zhang J, Tian S, Lou J, Chen Y. Familial cluster of COVID-19 infection from an asymptomatic. Crit Care. 2020 Mar 27;24(1):119. DOI: 10.1186/ s13054-020-2817-7.

  160. Jing QL, Liu MJ, Yuan J, Zhang ZB, Zhang AR, Dean NE, et al. Household secondary attack rate of COVID-19 and associated determinants. medRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Apr 15 [cited 2020 Apr 25]. Available at: https://www.medrxiv.org/content/10.1101 /2020.04.11.20056010v1

  161. Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020 May;63(5):706–11.

  162. Guan Q, Liu M, Zhuang YJ, Yuan Y, Wang SS, Li J, et al. [Epidemiological investigation of a family clustering of COVID-19]. Zhonghua Liu Xing Bing Xue ZaZhi. 2020 May 10;41(5):629–33. Chinese.

  163. Qiu YY, Wang SQ, Wang XL, Lu WX, Qiao D, Li JB, et al. [Epidemiological analysis on a family cluster of COVID-19]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Apr 10;41(4):506–9. Chinese.

  164. Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, et al. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis. 2020 Apr;20(4):410–1.

  165. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514–23.

  166. Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis. 2020 May 11;221(11):1757–61.

  167. Huang R, Xia J, Chen Y, Shan C, Wu C. A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China. Lancet Infect Dis. 2020 May;20(5):534–5.

  168. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral loading upper respiratory specimens of infected patients. N Engl J Med. 2020 Mar 19;382(12):1177–9.

  169. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020 Mar 5;382(10):970–1.

  170. Heald-Sargent T, Muller WJ, Zheng X, Rippe J, Patel AB, Kociolek LK. Age-related differences in nasopharyngeal severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate Coronavirus disease 2019 (COVID-19). JAMA Pediatr. 2020 Jul 30. DOI: 10.1001/jamapediatrics.2020.3651.

  171. Park YJ, Choe YJ, Park O, Park SY, Kim YM, Kim J, et al. Contact tracing during Coronavirus disease outbreak, South Korea, 2020. Emerg Infect Dis. 2020 Jul16;26(10). DOI: 10.3201/ eid2610.201315.

  172. Park SY, Kim YM, Yi S, Lee S, Na BJ, Kim CB, et al. Coronavirus disease outbreaking call center, South Korea. Emerg Infect Dis. 2020 Aug;26(8):1666–70.

  173. James A, Eagle L, Phillips C, Hedges DS, Bodenhamer C, Brown R, et al. High COVID-19 Attack Rate Among Attendees at Events at a Church - Arkansas, March 2020. MMWR Morb Mortal Wkly Rep. 2020 May 22;69(20):632–5.

  174. Jang S, Han SH, Rhee JY. Cluster of Coronavirus disease associated with fi tness dance classes, South Korea. Emerg Infect Dis. 2020 Aug;26(8):1917–20.

  175. Hamner L, Dubbel P, Capron I, Ross A, Jordan A, Lee J, et al. High SARS-CoV-2 attack rate following exposure at a choir practice - Skagit County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):606–10.

  176. Naserghandi A, Allameh SF, Saffarpour R. All about COVID-19 in brief. New Microbes New Infect. 2020 Apr 13;35:100678. DOI: 10.1016/j. nmni.2020.100678.

  177. Jalava K. First respiratory transmitted food borne outbreak? Int J Hyg Environ Health. 2020 May;226:113490.

  178. World Health Organization. COVID-19 and food safety: guidance for food businesses [Internet]. Geneva: World Health Organization; 2020 Apr 7 [cited 2020 Apr 30]. Available at: https://www.who.int/publications/i/ item/covid-19-and-food-safety-guidance-for -food-businesses

  179. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC); c2020. Food Safety Newsletters. Food safety and coronavirus disease 2019 (COVID-19); 2020 [cited 2020 Apr 28]. Available at: https://www.cdc.gov/foodsafe ty/newsletter/food-safety-and-Coronavirus.html

  180. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC); c2020. Frequently Asked Questions. Water; [cited 2020 Apr 30]. Available at: https://www.cdc.gov/ coronavirus/2019-ncov/php/water.html

  181. Yu F, Yan L, Wang N, Yang S, Wang L, Tang Y, et al. Quantitative detection andviral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis. 2020 Jul28;71(15):793–8.

  182. Wang XW, Li JS, Jin M, Zhen B, Kong QX, Song N, et al. Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J Virol Methods. 2005 Jun;126(1– 2):171–7.

  183. Casanova L, Rutala WA, Weber DJ, Sobsey MD. Survival of surrogate coronaviruses in water. Water Res. 2009 Apr;43(7):1893–8.

  184. Water Services Association of Australia - COVID- 19. SARS-CoV-2 - Water and Sanitation Fact Sheet [Internet]. Adelaide: Water Research Australia; [updated 2020 Mar 5; cited 2020 Apr 30]. 3 p. Available at: https://www.waterra.com .au/_r9550/media/system/attrib/fi le/2200/Water RA_FS_Coronavirus_V11.pdf

  185. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Publications. Overview. Water, sanitation, hygiene and waste management for SARS-CoV-2, the virus that causes COVID-19; 2020 Jul 29 [cited 2020 Aug 3]. 11 p. Available at: https://www.who.int/ publications-detail/water-sanitation-hygiene -and-waste-management-for-covid-19

  186. La Rosa G, Bonadonna L, Lucentini L, Kenmoe S, Suffredini E. Coronavirus in water environments: occurrence, persistence and concentration methods - A scoping review. Water Res. 2020 Jul 15;179:115899. DOI: 10.1016/j. watres.2020.115899.

  187. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: Centers for Disease Control and pfrevention (CDC); c2020. Coronavirus Disease 2019 (COVID-19). Health Care Workers. Clinical Questions about COVID-19: Questionsand Answers. Waste management; [updated 2020 Aug 4; cited 2020 Apr 30]. Available at: https://www.cdc.gov/coronavirus/2019 -ncov/hcp/faq.html#Waste-Management

  188. Huang YS, Vanlandingham DL, Bilyeu AN, Sharp HM, Hettenbach SM, Higgs S. SARS-CoV-2 failure to infect or replicate in mosquitoes: an extreme challenge. Sci Rep. 2020 Jul 17;10(1):11915. DOI: 10.1038/s41598-020-68882-7.

  189. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Coronavirus disease (COVID-19). Advice for the public. Myth busters; [cited 2020 Apr 30]; [about 6 p.]. Available at: https://www.who.int/emergencies/diseases/novel -coronavirus-2019/advice-for-public/myth-busters

  190. American Mosquito Control Association [Internet]. Sacramento, CA: American Mosquito Control Association; c2020. News and Press. Can mosquitoes transmit the coronavirus?; 2020 Mar 10 [cited 2020 Apr 30]. Available at: https://www .mosquito.org/news/492656/Can-Mosquitoes -Transmit-the-Coronavirus.htm

  191. Franchini M, Farrugia A, Velati C, Zanetti A, Romanň L, Grazzini G, et al. The impact of the SARS–CoV–2 outbreak on the safety and availability of blood transfusions in Italy. Vox Sang. 2020 Apr 2. DOI: 10.1111/vox.12928.

  192. Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev. 2020 Apr;34(2):75–80.

  193. Dodd RY, Stramer SL. COVID-19 and blood safety: help with a dilemma. Transfus Med Rev. 2020 Apr;34(2):73–4.

  194. Heneghan C, Brassey J, Jefferson T. SARSCoV- 2 viral load and the severity of COVID-19 [Internet]. Oxford: Centre for Evidence-Based Medicine; 2020 Mar 26 [cited Apr 17]. Available at: https://wwwcebmnet/covid-19/sars-cov-2-vi ral-load-and-the-severity-of-covid-19/

  195. Kwon SY, Kim EJ, Jung YS, Jang JS, Cho NS. Post-donation COVID-19 identifi cationin blood donors. Vox Sanguini [Internet]. Amsterdam: International Society of Blood Transmission; 2020 Apr 2 [cited 2020 Apr 17]. Available at: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ vox.12925

  196. Cho HJ, Koo JW, Roh SK, Kim YK, Suh JS, Moon JH, et al. COVID-19 transmission and blood transfusion: a case report. J Infect Public Health. 2020 May 13. DOI: 10.1016/j.jiph.2020.05.001.

  197. Liu W, Li H. COVID-19: Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. chemRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Jul 13 [cited 2020 Jul 25]. Available at: https://chemrxiv .org/articles/preprint/COVID19_Disease_ORF8 _and_Surface_Glycoprotein_Inhibit_Heme_Me tabolism_by_Binding_to_Porphyrin/11938173

  198. Chang L, Zhao L, Gong H, Wang L, Wang L. Severe acute respiratory syndrome coronavirus 2 RNA detected in blood donations. Emerg Infect Dis. 2020 Jul;26(7):1631–3.

  199. European Center for Disease Prevention and Control. Outbreak of acute respiratory syndrome associated with a novel Coronavirus, Wuhan, China; first update [Internet]. Stockholm: European Center for Disease Prevention and Control; 2020 Jan 22 [cited 2020 May 1]. 12 p. Available at: https://www.ecdc.europa.eu/sites/default/ files/documents/Risk-assessment-pneumonia -Wuhan-China-22-Jan-2020.pdf

  200. American Association of Blood Banks. Update: impact of 2019 novel coronavirus and blood safety [Internet]. Maryland: American Association of Blood Banks; 2020 [cited 2020 May 1]. 6 p. Available at: http://www.aabb.org/advocacy/ regulatorygovernment/Documents/Impact-of -2019-Novel-Coronavirus-on-Blood-Donation.pdf

  201. The New York Blood Center Enterprises. COVID- 19 and Blood Donation [Internet]. New York: New York Blood Center Enterprises; c2020 [cited 2020 May 1]. Available at: https://www.nybc .org/donate-blood/covid-19-and-blood-donation -copy/

  202. Michaels MG, La Hoz RM, Danziger-Isakov L, Blumberg EA, Kumar D, Green M, et al. Coronavirus disease 2019: implications of emerging infections for transplantation. Am J Transplant. 2020 Jul;20(7):1768–72.

  203. Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, et al. Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI). Hepatol Int. 2020 Jul;14(4):429–31.

  204. Bhoori S, Rossi RE, Citterio D, Mazzaferro V. COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):532–3.

  205. Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. COVID-19 infection in kidney transplant recipients. Kidney Int. 2020 Jun;97(6):1076–82.

  206. Wang R, Liao C, He H, Hu C, Wei Z, Hong Z, et al. COVID-19 in hemodialysis patients: a report of 5 cases. Am J Kidney Dis. 2020 Jul;76(1):141–3.

  207. Ferrey AJ, Choi G, Hanna RM, Chang Y, Tantisattamo E, Ivaturi K, et al. A case of novel Coronavirus disease 19 in a chronic hemodialysis patient presenting with gastroenteritis and developing severe pulmonary disease. Am J Nephrol. 2020;51(5):337–42.

  208. American Society of Nephrology. Information for screening and management of COVID-19 in the outpatient dialysis facility [Internet]. Washington, D.C.: American Society of Nephrology; 2020 Mar 13 [cited 2020 Apr 30]. 7 p. Available at: https:// www.asn-online.org/g/blast/fi les/DIALYSIS_CO VID_2019_Update_03.13.2020_FINAL.pdf

  209. Centers for Disease Control and Prevention (CDC). Atlanta: Centers or Disease Control and Prevention (CDC); c2020. Coronavirus Disease (COVID-19). Healthcare Workers. Considerations for providing hemodialysis to patients with suspected or confi rmed COVID-19 in acute care settings; [updated 2020 Jul 7; cited 2020 Apr 30]. Available at: https://www.cdc.gov/ coronavirus/2019-ncov/hcp/dialysis/dialysis-in -acute-care.html

  210. Ikizler TA, Kliger AS. Minimizing the risk of COVID-19 among patients on dialysis. Nat Rev Nephrol. 2020 Jun;16(6):311–3.

  211. Weiner DE, Watnick SG. Hemodialysis and COVID-19: an Achilles’ heeling the pandemic health care response in the United States. Kidney Med. 2020 May–Jun;2(3):227–30.

  212. Kliger AS, Silberzweig J. Mitigating risk of COVID- 19 in dialysis facilities. Clin J Am Soc Nephrol. 2020 May 7;15(5):707–9.

  213. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan,China. JAMA. 2020 Feb 7. DOI: 10.1001/jama.2020.1585.

  214. Jiang WY, Xiong R, Lu ZL. Clinical practice of prevention and treatment of novel Coronavirus infection in the medical personnel and surgical patients in the Department of Thoracic Surgery of Hospitals in Wuhan. Chin J Thoracic Cardiovasc Surg. 2020;27:364–70.

  215. Cao G, Tang S, Yang D, Shi W, Wang X, Wang H, et al. One nosocomial cluster following with a familial cluster of COVID-19 cases: the potential transmission risk inpatients with negative swab tests [Internet]. North Carolina: Res Square; 2020 May 29 [cited 2020 Jul 20].15 p. Available at: https://www.researchsquare.com/article/rs -17879/v1

  216. Wang Q, Kuang W, Ping W. Prevention and treatment of cross infection of novel Coronavirus pneumonia in thoracic surgery ward. Chin J Thoracic Cardiovasc Surg. 2020;27:371–5.

  217. Zhou Q, Gao Y, Wang X, Liu R, Du P, Wang X, et al. Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis. medRxiv[Internet]. New York: Cold Spring Harbor Lab; 2020 Apr 17 [cited 2020 Apr 25]. Available at: https://www.medrxiv.org/ content/10.1101/2020.04.14.20065730v1

  218. Wee LE, Conceicao EP, Sim XYJ, Aung MK, Tan KY, et al. Minimising intra-hospital transmission of COVID-19: the role of social distancing. J Hosp Infect. 2020 Jun;105(2):113–5.

  219. Wong SCY, Kwong RTS, Wu TC, Chan JWM, Chu MY, Lee SY, et al. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong. J Hosp Infect. 2020 Jun;105(2):119–27.

  220. Wang L, Chen X, Ye L. Integrated infection control strategy to minimize nosocomial infection during outbreak of COVID-19 among ED healthcare workers. J Emerg Nursing. 2020 Jul;46(4):424–5.

  221. Klompas M. Coronavirus disease 2019 (COVID- 19): protecting hospitals from the invisible. Ann Intern Med. 2020 May 5;172(9):619–20.

  222. Simonds A, Hanak A, Chatwin M, Morrell M, Hall A, Parker KH, et al. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess. 2010 Oct;14(46):131–72.

  223. Hui D, Chan M, Chow B. Aerosol dispersion during various respiratory therapies: a risk assessment model of nosocomial infection to health care workers. Hong Kong Med J. 2014 Aug;20 Suppl 4:9–13.

  224. Cabrini L, Landoni G, Zangrillo A. Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure. Lancet. 2020 Feb 29;395(10225):685. DOI: 10.1016/S0140- 6736(20)30359-7.

  225. Chen X, Tian J, Li G, Li G. Initiation of a new infection control system for the COVID-19 outbreak. Lancet Infect Dis. 2020 Apr;20(4):397–8.

  226. Peng J, Ren N, Wang M, Zhang G. Practical experiences and suggestions for the ’eagle-eyed observer’: a novel promising role for controlling nosocomial infection in the COVID-19 outbreak. J Hosp Infect. 2020 May;105(1):106–7.

  227. Varia M, Wilson S, Sarwal S, McGeer A, Gournis E, Galanis E. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ. 2003 Aug 19;169(4):285–92.

  228. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak ofsevere acute respiratory syndrome in Hong Kong. N Engl J Med. 2003 May 15;348(20):1986–94.

  229. Hunter E, Price DA, Murphy E, van der Loeff IS, Baker KF, Lendrem D, et al. First experience of COVID-19 screening of health-care workers in England. Lancet. 2020 May 2;395(10234):e77–e8.

  230. Liu M, He P, Liu HG, Wang XJ, Li FJ, Chen S, et al. [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]. Zhonghua Jie He He HuXi Za Zhi. 2020 Feb 17;43:E016. DOI: 10.3760/ cma.j.issn.1001-0939.2020.0016. Chinese.

  231. Zhan M, Qin Y, Xue X, Zhu S. Death from Covid- 19 of 23 health care workers in China. N Engl J Med. 2020 Jun 4;382(23):2267–8.

  232. Ran L, Chen X, Wang Y, Wu W, Zhang L, Tan X. Risk factors of healthcare workers with corona virus disease 2019: a retrospective cohort study in a designated hospital of Wuhan in China. Clin Infect Dis. 2020 Mar 17. pii: ciaa287. DOI: 10.1093/cid/ciaa287.

  233. Ng K, Poon BH, Kiat Puar TH, Shan Quah JL, Loh WJ, Wong YJ, et al. COVID-19 and the risk to health care workers: a case report. Ann Intern Med. 2020 Jun 2;172(11):766–7.

  234. COVID-19: protecting health-care workers. Lancet. 2020 Mar 21;395(10228):922.

  235. World Health Organization [Internet]. Copenhagen: World Health Organization Regional Offi ce for Europe; c2020. Newsroom. Detail. Shortage of personal protective equipment endangering health workers worldwide; 2020 Mar 3 [cited 2020 Apr 27]. Available at: https://www.who.int/ news-room/detail/03-03-2020-shortage-of-per sonal-protective-equipment-endangering-health-workers-worldwide

  236. Cheng VC, Wong SC, Yuen KY. Estimating Coronavirus disease 2019 infection risk in health care workers. JAMA Netw Open. 2020 May 1;3(5):e209687. DOI: 10.1001/jamanetworkopen. 2020.9687.

  237. Kluytmans-van den Bergh MFQ, Buiting AGM, Pas SD, Bentvelsen RG, van denBijllaardt W, van Oudheusden AJG, et al. Prevalence and clinical presentation of health care workers with symptoms of Coronavirus disease 2019 in 2 Dutchhospitals during an early phase of the pandemic. JAMA Netw Open. 2020 May 1;3(5):e209673. DOI: 10.1001/jamanetworkopen.2020.9673.

  238. Iken O, Abakporo U, Ayobami O, Attoye T. COVID-19: Travel health and the implications for sub -Saharan Africa. Travel Med Infect Dis. 2020 May–Jun;35:101645. DOI: 10.1016/j. tmaid.2020.101645.

  239. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Publication. Overview. Interim guidance: management of ill travellers atpoints of entry–international airports, ports and ground crossings–in the context ofthe COVID-19 outbreak; 2020 Mar 19 [cited 2020 Apr 27]. Available at: https://www.who .int/publications/i/item/10665-331512

  240. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Newsroom. Article. Updated WHO recommendations for international traffic in relation to COVID-19 outbreak; 2020 Feb 29 [cited 2020 Apr 27]. Available at: https://www.who.int/news-room/articles-detail/ updated-who-recommendations-for-internation al-traffi c-in-relation-to-covid-19-outbreak

  241. Zhong P, Guo S, Chen T. Correlation between travellers departing from Wuhan before the Spring Festival and subsequent spread of COVID- 19 to all provinces in China. J Travel Med. 2020 May 18;27(3). pii: taaa036. DOI: 10.1093/ jtm/taaa036.

  242. Zhao S, Zhuang Z, Cao P, Ran J, Gao D, Lou Y, et al. Quantifying the association between domestic travel and the exportation of novel coronavirus (2019-nCoV) cases from Wuhan, China in 2020: a correlational analysis. J Travel Med. 2020 Mar 13;27(2). pii: taaa022. DOI: 10.1093/jtm/taaa022.

  243. Devi S. Travel restrictions hampering COVID-19 response. Lancet. 2020 Apr 25;395(10233):1331–2.

  244. Ng O-T, Marimuthu K, Chia PY, Koh V, Chiew CJ, De Wang L, et al. SARS-CoV-2 infection among travelers returning from Wuhan, China. N Engl J Med. 2020 Apr 9;382(15):1476–8.

  245. Kuan MM, Lin T, Chuang JH, Wu HS. Epidemiological trends and the effect of airport fever screening on prevention of domestic dengue fever outbreaks in Taiwan,1998-2007. Int J Infect Dis. 2010 Aug;14(8):e693–e7.

  246. Thwaites GE, Day NP. Approach to fever in the returning traveler. N Engl J Med. 2017 Feb 9;376(6):548–60.

  247. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019- nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020 Feb;25(5). DOI: 10.2807/1560-7917. ES.2020.25.5.2000062.

  248. Okada P, Buathong R, Phuygun S, Thanadachakul T, Parnmen S, Wongboot W, et al. Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020. Euro Surveill. 2020 Feb;25(8). DOI: 10.2807/1560-7917. ES.2020.25.8.2000097.

  249. Hoehl S, Rabenau H, Berger A, Kortenbusch M, Cinatl J, Bojkova D, et al. Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med. 2020 Mar 26;382(13):1278–80.

  250. Samaan G, Patel M, Spencer J, Roberts L. Border screening for SARS in Australia: what has been learnt? Med J Aust. 2004 Mar 1;180(5):220–3.

  251. Quilty BJ, Clifford S, Flasche S, Eggo RM; CMMID nCoV working group. Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV). Euro Surveill. 2020 Feb;25(5). DOI: 10.2807/1560-7917. ES.2020.25.5.2000080.

  252. Bwire GM, Paulo LS. Coronavirus disease-2019: is fever an adequate screening for the returning travelers? Trop Med Health. 2020 Mar 9;48:14.

  253. Anzai A, Kobayashi T, Linton NM, Kinoshita R, Hayashi K, Suzuki A, et al. Assessing the impact of reduced travel on exportation dynamics of novel coronavirus infection (COVID-19). J Clin Med. 2020 Feb 24;9(2). pii: E601.DOI: 10.3390/ jcm9020601.

  254. Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020 Apr 24;368(6489):395–400.

  255. Karami M, Doosti-Irani A, Ardalan A, Gohari- Ensaf F, Berangi Z, Massad E, et al. Public health threats in mass gatherings: asystematic review. Disaster Med Public Health Prep. 2019 Dec;13(5–6):1035–46.

  256. Memish ZA, Steffen R, White P, Dar O, Azhar EI, Sharma A, et al. Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events. Lancet. 2019 May 18;393(10185):2073–84.

  257. Ebrahim SH, Memish ZA. COVID-19 - the role of mass gatherings. Travel Med Infect Dis. 2020 Mar–Apr;34:101617. DOI: 10.1016/j. tmaid.2020.101617.

  258. McCloskey B, Zumla A, Ippolito G, Blumberg L, Arbon P, Cicero A, et al. Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma. Lancet. 2020 Apr 4;395(10230):1096–9.

  259. Petersen E, Memish ZA, Zumla A, Maani AA. Transmission of respiratory tract infections at mass gathering events. Curr Opin Pulm Med. 2020 May;26(3):197–202.

  260. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3). DOI:10.1016/j.ijantimicag.2020.105924.

  261. Nunan D, Brassey J. What is the evidence for mass gatherings during global pandemics? A rapid summary of best-available evidence [Internet]. Oxford: Center for Evidene-Based Medicine (CEBM); 2020 Mar 20 [cited 2020 May 4]. Available at: https://www.cebm.net/covid-19/ what-is-the-evidence-for-mass-gatherings-during- global-pandemics/

  262. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC); c2020. Coronavirus disease (COVID-19). Community, Work and Schools. Gatherings and Community Events: plan, prepare and respond; 2020 Jun 12 [cited 2020 Apr 28]. Available at: https://www.cdc. gov/coronavirus/2019-ncov/community/largeevents/ index.html

  263. World Health Organization. Interim guidance: Key planning recommendations form as gatherings in the context of the current COVID-19 outbreak [Internet]. Geneva: World Health Organization; 2020 [cited 2020 Apr 30]. Available at: https://apps.who.int/ iris/bitstream/handle/10665/331004/WHO- 2019-nCoV-POEmassgathering-2020.1 -eng.pdf?sequence=1&isAllowed=y

  264. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta:Centers for Disease Control and Prevention (CDC); c2020. Coronavirus disease (COVID-19). Get Your Mass Gatherings or Large Community Events Ready; 2020 [cited 2020 Apr 28]. Available at: https:// www.cdc.gov/coronavirus/2019-ncov/commu nity/large-events/mass-gatherings-ready-for -covid-19.html

  265. World Health Organization [Internet]. Geneva: World Health Organization; c2020.Q&A on Mass Gatherings and COVID-19; 2020 [cited 2020 Apr 30]. Available at: https://www.who.int/news-room/qa- detail/q-a-on-mass-gatherings-and-covid-19

  266. Rodríguez-Morales AJ, Gallego V, Escalera- Antezana JP, Mendez CA, Zambrano LI, Franco- Paredes C, et al. COVID-19 in Latin America: the implications of the fi rst confi rmed case in Brazil. Travel Med Infect Dis. 2020 May–Jun;35:101613. DOI: 10.1016/j.tmaid.2020.101613.

  267. Kluge HHP, Jakab Z, Bartovic J, D’Anna V, Severoni S. Refugee and migrant health in the COVID-19 response. Lancet. 2020 Apr 18;395(10232):1237–9.

  268. COVID-19 will not leave behind refugees and migrants. Lancet. 2020 Apr 4;395(10230):1090.

  269. World Health Organization Regional Office for Europe [Internet]. Geneva: World Health Organization; c2020. Health Topics. COVID-19: ensuring refugees and migrants are not left behind; 2020 Apr 16 [cited 2020 Apr 27]. Available at: http://www.euro.who.int/en/health-topics/ health-determinants/migration-and-health/news/ news/2020/4/covid-19-ensuring-refugees-and -migrants-are-not-left-behind

  270. World Health Organization Regional Offi ce for Europe [Internet]. Interim guidance for refugee and migrant health in relation to COVID-19 in the WHO European Region Geneva: World Health Organization; 2020 Mar 25 [cited 2020 Apr 27]. Available at: http://www.euro .who.int/en/health-topics/health-determinants/ migration-and-health/publications/2020/ interim-guidance-for-refugee-and-migrant -health-in-relation-to-covid-19-in-the-who-euro pean-region-2020

  271. Tsai J, Wilson M. COVID-19: a potential public health problem for homeless populations. Lancet Public Health. 2020 Apr;5(4):e186–e7.

  272. Baggett TP, Hwang SW, O’Connell JJ, Porneala BC, Stringfellow EJ, Orav EJ, et al. Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med. 2013 Feb 11;173(3):189–95.

  273. Lima NNR, de Souza RI, Feitosa PWG, Moreira JLS, da Silva CGL, Neto MLR. People experiencing homelessness: their potential exposure to COVID-19. Psychiatry Res. 2020 Apr 11;288:112945. DOI: 10.1016/j.psychres. 2020.112945.

  274. Leung CS, Ho MM, Kiss A, Gundlapalli AV, Hwang SW. Homelessness and the response to emerging infectious disease outbreaks: lessons from SARS. J Urban Health. 2008 May;85(3):402–10.

  275. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC); c2020. Coronavirus Disease 2019 (COVID-19). Community, Work and School. Interim Guidance for Homeless Service Providers to Plan and Respond to Coronavirus Disease 2019 (COVID-19); 2020 Aug 5 [cited 2020 Apr 28]. Available at: https://www.cdc.gov/ coronavirus/2019-ncov/community/homeless -shelters/plan-prepare-respond.html

  276. National Institute of Drug Abuse [Internet]. Maryland: National Institute of Drug Abuse; c2020. Nora’s blog. COVID-19: Potential implications for individuals with substance use disorders; 2020 Apr 6 [cited 2020 Apr 28]; [about 8 p.]. Available at: https://www.drugabuse.gov/about-nida/noras -blog/2020/04/covid-19-potential-implications -individuals-substance-use-disorders

  277. Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G, et al. COVID-19 and substance use disorders: recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper. Basic Clin Neurosci. 2020 Mar– Apr;11(2):133–46.

  278. Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Inter Med. 2020 Jul 7;173(1):61–2.

  279. Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 2020 Apr;8(4):e20. DOI: 10.1016/ S2213-2600(20)30117-X.

  280. Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv [Internet]. New York: Cold Spring Harbor Lab; 2020 Feb 28 [cited 2020 Apr 25]. Available at: https://www.medrxiv.org/content/10.110 1/2020.02.05.20020107v3

  281. Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020 May 14;55(5). pii: 2000688. DOI: 10.1183/13993003.00688-2020.

  282. Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020 Mar 20;18:20. DOI: 10.18332/tid/119324.

  283. Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, et al. The impact of COPD and smoking history on the severity of Covid-19: a systemic review and meta-analysis. J Med Virol. 2020 Apr 15. DOI: 10.1002/jmv.25889.

  284. Rossato M, Russo L, Mazzocut S, Di Vincenzo A, Fioretto P, Vettor R. Current smoking is not associated with COVID-19. Eur Respir J. 2020 Jun 4;55(6). pii:2001290. DOI: 10.1183/13993003.01290-2020.

  285. Farsalinos K, Barbouni A, Niaura R. Smoking, vaping and hospitalization for COVID-19 [Internet]. London: Qeios; 2020 Apr 4 [cited 2020 May 25]. Available at: https://www.qeios .com/read/Z69O8A.13

  286. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. Eur Respir J. 2020 May 14;55(5). pii: 2000547. DOI: 10.1183/13993003.00547-2020.

  287. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. PMID: 32232218.

  288. Miyara M, Tubach F, Pourcher V, Morelot-Panzini C, Pernet J, Haroche J, et al. Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19 [Internet]. London: Qeios; 2020 Apr 21 [cited 2020 May 25]. Available at: https://www.qeios.com/read/WPP19W.3

  289. Changeux JP, Amoura Z, Rey F, Miyara M. A nicotinic hypothesis for Covid-19 with preventive nd therapeutic implications [Internet]. London: Qeios; 2020 Apr 21 [cited 2020 May 20]. Available at: https://www.qeios.com/read/FXGQSB

  290. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Q&A on smoking and COVID-19; 2020 May 27 [cited 2020 Apr 27]. Available at: https://www.who.int/news -room/q-a-detail/q-a-on-smoking-and-covid-19

  291. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020 Feb 24. DOI: 10.1001/jama.2020.2648.

  292. World Health Organization [Internet]. Geneva: World Health Organization; c2020. Tobacco Free Initiative. Know the Truth. Tobacco and waterpipe use increases the risk of suffering from COVID-19; 2020 [cited 2020 Apr 27]. Available at: http://www.emro.who.int/tfi /know-the-truth/ tobacco-and-waterpipe-users-are-at-increased -risk-of-covid-19-infection.html

  293. Madison MC, Landers CT, Gu BH, Chang CY, Tung HY, You R, et al. Electronic cigarettes disrupt lung lipid homeostasis and innate immunity independent of nicotine. J Clin Invest. 2019 Oct 1;129(10):4290–304.

  294. Simooya OO. Infections in prison in low and middle income countries: prevalence and prevention strategies. Open Infect Dis J. 2010;4:33–7.

  295. Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011 Mar12;377(9769):956–65.

  296. Kinner SA, Young JT, Snow K, Southalan L, López-Acuńa D, Ferreira-Borges C, et al. Prisons and custodial settings are part of a comprehensive response to COVID-19. Lancet Public Health. 2020 Apr;5(4):e188–e9.

  297. Hawks L, Woolhandler S, McCormick D. COVID- 19 in prisons and jails in the United States. JAMA Intern Med. 2020 Apr 28. DOI: 10.1001/ jamainternmed.2020.1856.

  298. Walmsley R. World Prison Population List. 12th ed [Internet]. London: Institute for Criminal Policy Research, University of London; 2018 Sep [cited 2020 May 4].19 p. Available at: https://www.prison studies.org/sites/default/files/resources/down loads/wppl_12.pdf

  299. Yang H, Thompson JR. Fighting covid-19 outbreaks in prisons. BMJ. 2020;369:m1362.

  300. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: Centers for Disease Control and Prevention (CDC); c2020. Coronavirus disease (COVID-19). Your Health.People who are at higher risk for severe illness; [updated 2020 Jun 25; cited 2020 Apr 28]. Available at: https://www.cdc.gov/coronavirus/2019-ncov/ need-extra-precautions/people-at-higher-risk .html

  301. World Health Organization. Preparedness, prevention and control of COVID-19 inprisons and places of detention [Internet]. Copenhagen: World Health Organization Regional Office for Europe; 2020 Mar 15 [cited 2020 Apr 27]. 31 p. Available at: http://www.euro.who.int/__data/assets/pdf_fi le /0019/434026/Preparedness-prevention-and-con trol-of-COVID-19-in-prisons.pdf




2020     |     www.medigraphic.com